Exploring Ingevity Corporation (NGVT) Investor Profile: Who’s Buying and Why?

Have you ever wondered who the major players are behind Ingevity Corporation (NGVT) and what drives their investment decisions? As of December 30, 2024, institutional investors hold a significant 98.17% of Ingevity's shares, with the top holders including BlackRock, Inc. owning 16.46% (5,981,328 shares) and Vanguard Group, Inc. with 11.46% (4,164,419 shares). But why are these firms and others investing in Ingevity, and what do they see in the company's future, especially considering its recent strategic moves and a projected 26.8% increase in 2025 earnings? Let's delve into the investor profile of Ingevity and uncover the motivations behind their investment strategies.

Ingevity Corporation (NGVT) Who Invests in Ingevity Corporation and Why?

Understanding the investor profile of Ingevity Corporation (NGVT) provides valuable insights into the market's perception of the company. Investors are drawn to Ingevity for a variety of reasons, influenced by the company's growth prospects, dividend payouts, and its strategic position within its operating markets.

Key Investor Types: A diverse range of investors hold Ingevity Corporation (NGVT) stock. These can be broadly categorized as:

• Retail Investors: Individual investors who buy shares for their personal accounts. Their investment decisions are often based on factors like brand recognition, dividend yield, and perceived stability.
• Institutional Investors: Entities such as mutual funds, pension funds, insurance companies, and endowments that invest on behalf of their clients. These investors typically have a longer-term investment horizon and conduct in-depth fundamental analysis.
• Hedge Funds: Actively managed investment funds that may employ a variety of strategies, including long-short equity, event-driven, and macro trading. Their investment decisions are often driven by short-term opportunities and a focus on absolute returns.

Investment Motivations: Several factors attract investors to Ingevity Corporation (NGVT):

• Growth Prospects: Investors are attracted to Ingevity's potential for future growth, driven by increasing demand for its products in various applications.
• Market Position: Ingevity's leading positions in niche markets provide a competitive advantage and contribute to stable revenue streams.

Investment Strategies: The strategies employed by Ingevity Corporation (NGVT) investors vary depending on their investment goals and risk tolerance:

• Long-Term Holding: Many institutional investors adopt a long-term holding strategy, focusing on Ingevity's consistent performance and dividend payouts.
• Short-Term Trading: Hedge funds and other active traders may engage in short-term trading strategies to capitalize on price fluctuations and market volatility.
• Value Investing: Value investors seek undervalued companies with strong fundamentals. They may be attracted to Ingevity if they believe the stock price is below its intrinsic value.

Examining the investor composition and their motivations can offer a deeper understanding of market sentiment towards Breaking Down Ingevity Corporation (NGVT) Financial Health: Key Insights for Investors.

Ingevity Corporation (NGVT) Institutional Ownership and Major Shareholders of Ingevity Corporation (NGVT)

Institutional ownership in Ingevity Corporation (NGVT) provides insights into market sentiment and the potential stability of its stock. Large institutional investors often conduct thorough research before investing, and their activity can significantly influence stock price and company strategy. Examining the top institutional holders and recent changes in their positions offers a valuable perspective on the company's investor profile.

Here's an overview of Ingevity Corporation's (NGVT) institutional ownership:

• Top Institutional Investors: The largest institutional investors in Ingevity Corporation (NGVT), reflecting significant stakes in the company.
• Recent Changes in Ownership: Recent increases or decreases in institutional holdings, which can signal shifts in investor confidence.
• Impact of Institutional Investors: The role these large investors play in shaping the company’s stock price and influencing its strategic decisions.

As of the latest data, the top institutional investors in Ingevity Corporation (NGVT) include:

• BlackRock Inc.
• The Vanguard Group Inc.
• Capital Research & Management Co.
• Государственная корпорация «Банк развития и внешнеэкономической деятельности (Внешэкономбанк)»
• Государственная корпорация развития «ВЭБ.РФ»

Changes in institutional ownership can indicate the evolving sentiment of major investors. Increases in holdings may suggest growing confidence in Ingevity Corporation's (NGVT) future prospects, while decreases could reflect concerns about performance or market conditions. Recent activity in institutional ownership provides valuable context for understanding the current investor landscape.

Institutional investors play a crucial role in Ingevity Corporation's (NGVT) stock performance and strategic direction. Their investment decisions can drive trading volume and influence stock valuation. Additionally, these large shareholders may engage with the company's management to advocate for specific strategies or governance practices. The presence of significant institutional ownership often correlates with greater market scrutiny and accountability, which can be beneficial for long-term value creation.

The following table summarizes key aspects of institutional ownership in Ingevity Corporation (NGVT):

Understanding the composition and activity of Ingevity Corporation's (NGVT) institutional investor base is essential for assessing market sentiment and potential future performance. Monitoring changes in ownership and the engagement of these major shareholders can provide valuable insights into the company's strategic direction and long-term outlook.

To gain further insights into Ingevity Corporation's (NGVT) strategic objectives, consider exploring Mission Statement, Vision, & Core Values of Ingevity Corporation (NGVT).

Ingevity Corporation (NGVT) Key Investors and Their Impact on Ingevity Corporation (NGVT)

Understanding the investor profile of Ingevity Corporation (NGVT) provides valuable insights into the company's stability, strategic direction, and potential for growth. Examining who is investing in Ingevity Corporation (NGVT) and their recent activities can offer clues about market sentiment and future performance. Here’s an overview of notable investors and their influence on Ingevity Corporation (NGVT).

While specific details on all key investors and their exact impact can fluctuate, we can identify categories of investors and illustrative examples to understand the landscape.

Types of Investors in Ingevity Corporation (NGVT):

• Institutional Investors: These include mutual funds, pension funds, hedge funds, and insurance companies. They manage large sums of money and often hold significant stakes in publicly traded companies like Ingevity Corporation (NGVT).
• Individual Investors: These are retail investors who buy and sell shares for their own accounts.
• Activist Investors: These investors purchase significant stakes in a company with the goal of influencing its management and strategic direction.
• Company Insiders: This category includes executives and board members who own shares of the company. Their transactions are closely watched as they may indicate their confidence in the company's future prospects.

Examples of Institutional Investors (Illustrative):

It's important to note that specific holdings and investment firms can change frequently. For illustrative purposes, here are the types of firms that might hold significant positions:

• Vanguard Group: Known for its index funds and low-cost investment options, Vanguard often holds large positions in many publicly traded companies.
• BlackRock Fund Advisors: As one of the world's largest asset managers, BlackRock typically has substantial holdings in major companies.
• State Street Corporation: Another major asset manager that invests in a wide range of companies.

Investor Influence:

The influence of these investors can manifest in several ways:

• Voting Rights: Large institutional investors wield significant voting power, allowing them to influence decisions on matters such as board elections, executive compensation, and major corporate actions.
• Market Sentiment: Significant buying or selling activity by large investors can impact the stock price and influence market sentiment.
• Engagement with Management: Institutional investors often engage with company management to discuss performance, strategy, and governance issues.
• Activist Campaigns: Activist investors may launch public campaigns to push for specific changes, such as cost-cutting measures, asset sales, or strategic shifts.

Recent Moves:

Monitoring recent moves by key investors, such as buying or selling large stakes, can provide insights into their outlook on the company. For instance, a large purchase by an institutional investor might signal confidence in Ingevity Corporation (NGVT)'s future prospects, while a significant sale could indicate concerns.

Example Table of potential Recent Transactions (Illustrative):

Note: The data above is purely illustrative and does not represent actual transactions.

Keeping an eye on major investors and their actions can offer valuable context for understanding Ingevity Corporation (NGVT)'s trajectory. For additional insights, you might find this resource helpful: Ingevity Corporation (NGVT): History, Ownership, Mission, How It Works & Makes Money.

Ingevity Corporation (NGVT) Market Impact and Investor Sentiment

Investor sentiment and market reactions significantly influence Ingevity Corporation's stock performance. Recent activity shows a mix of optimism and concern among major shareholders and analysts.

Here's an overview of the investor profile, sentiment, and market reactions surrounding Ingevity:

• Investor Sentiment: Mixed, with some institutions increasing their positions while others reduced theirs in Q4 2024.
• Recent Market Reactions: The stock price experienced volatility, reacting to executive changes and broader market conditions.
• Analyst Perspectives: Analysts' ratings vary, with price targets reflecting both bullish and cautious outlooks.

To delve deeper into Ingevity's financial standing, check out: Breaking Down Ingevity Corporation (NGVT) Financial Health: Key Insights for Investors

Major Institutional Investors

Institutional investors hold a significant portion of Ingevity's shares. As of recent filings:

• BlackRock Inc. holds 5.98 million shares, representing 16.41% of the company, valued at approximately $191.16 million.
• Vanguard Group Inc. holds 4.16 million shares, accounting for 11.43%, with a value of around $133.09 million.
• Wellington Management Group, LLP possesses 2.24 million shares, or 6.15%, valued at $71.59 million.
• State Street Corporation owns 1.61 million shares, which is 4.42% of the company, worth approximately $51.49 million.

Recent Investment Moves

Several institutional investors have recently adjusted their stakes in Ingevity:

• MAPLE ROCK CAPITAL PARTNERS INC. increased its holdings by 429,816 shares (over 1000% increase) in Q4 2024, with an estimated value of $17.52 million.
• AMERICAN CENTURY COMPANIES INC added 398,800 shares (+37.7%) in Q4 2024, valued at around $16.25 million.
• VISION ONE MANAGEMENT PARTNERS, LP increased its position by 298,157 shares (+265.0%) in Q4 2024, worth approximately $12.15 million.
• Conversely, GLENMEDE TRUST CO NA reduced its stake by 280,414 shares (-98.1%) in Q4 2024, with an estimated value of $11.43 million.
• MESIROW INSTITUTIONAL INVESTMENT MANAGEMENT, INC. eliminated its position, selling 213,807 shares (-100.0%) in Q4 2024, valued at $8.71 million.

Market Reaction to Key Events

The stock market has reacted to several key events involving Ingevity:

• CEO Departure (October 2024): The sudden departure of President and CEO John Fortson in October 2024 led to a stock drop of over 14%.
• Stock Performance (March 2025): Ingevity's stock experienced a 38% decrease over three years, compared to a market return of about 27%. There was also a 17% drop in about a month.
• BMO Capital Upgrade (February 2025): BMO Capital upgraded Ingevity's outlook from Market Perform to Outperform, with a price target of $65.

Analyst Perspectives and Price Targets

Analysts' opinions on Ingevity vary, with price targets reflecting different expectations for the company's future performance. Here’s a summary of recent analyst actions:

• The average one-year price target for Ingevity is $55.34 per share as of February 20, 2025.
• Price forecasts range from a low of $45.45 to a high of $64.05.
• Michael Sison from Wells Fargo lowered the rating to Equal-Weight with a price target of $45.00 in July 2024.
• John McNulty from BMO Capital raised the rating to Market Perform with a price target of $55.00 in July 2024.
• Christopher Kapsch from Loop Capital raised the rating to Hold with a price target of $56.00 in July 2024.
• Ian Zaffino from Oppenheimer raised the rating to Outperform with a price target of $58.00 in July 2024.
• Daniel Rizzo from Jefferies raised the rating to Buy with a price target of $62.00 in July 2024.

Ownership Structure

The ownership structure of Ingevity is distributed among institutional investors, insiders, and retail investors:

• Institutional Investors: Approximately 88.71%
• Insiders: 0.84%
• Public Companies and Individual Investors: 10.45%

Financial Performance

Ingevity has demonstrated both strengths and weaknesses in its recent financial performance:

• Revenue: In 2024, Ingevity reported revenues of over $1.4 billion, marking the third-highest year in its history.
• Adjusted EBITDA: The company achieved an adjusted EBITDA of over $362 million, with a 26% adjusted EBITDA margin.
• Free Cash Flow: Ingevity generated $51 million in free cash flow, exceeding prior guidance.

Factors Influencing Stock Price

Several factors have influenced Ingevity's stock price, as noted in an April 2025 analysis:

• Price to Sales Multiple: A decrease in the Price to Sales (P/S) ratio had a negative impact.
• Revenues: Stable revenues of $1.4 billion had a positive influence.
• Shares Outstanding: A reduction in shares outstanding also contributed positively.

Lobbying Activities

In Q1 2025, Ingevity disclosed $80,000 in lobbying expenses, focusing on issues such as infrastructure policy and chemical approval submissions.

Summary of Investor Sentiment

Overall, investor sentiment towards Ingevity Corporation appears mixed. While some analysts and institutional investors express confidence in the company's strategic direction and potential for growth, others remain cautious due to market volatility and recent financial performance. The company's stock is influenced by executive changes, product launches, and broader economic factors, making it essential for investors to stay informed and consider diverse perspectives.